ReviewCancers2025

Blocking Tumoral Angiogenesis VEGF/VEGFR Pathway: Bevacizumab-20 Years of Therapeutic Success and Controversy.

Elena Chitoran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.